Goodwin advised Mercy BioAnalytics, Inc. on the deal. Mercy BioAnalytics, Inc. announced its $41 million Series A financing round. The financing was led by Novalis LifeSciences, with...
Mercy BioAnalytics’ $41 Million Series A Financing
Weaviate.io’s $50 Million Series B Funding Round
Goodwin Procter advised Weaviate.io on the deal. Weaviate.io announced its $50 million Series B funding round led by Index Ventures with participation from Battery Ventures. Weaviate’s existing...
Landmark Bio’s Opening of State-of-the-art full-spectrum Development
Goodwin Procter advised Landmark Bio™ on the deal. Landmark Bio™ announced the opening of its state-of-the-art full-spectrum development and biomanufacturing facility in Watertown, Massachusetts. The 44,000 square-foot...
2U’s $800 Million Acquisition of edX
Paul Hastings advised 2U, Inc. on the deal while Goodwin Procter represented edX. 2U, Inc., a global leader in education technology, announced a definitive agreement to acquire...